D-amino acid oxidase mutant and application thereof in preparation of l-phosphinothricin

US2025163390A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025163390-A1
Application numberUS-202318840224-A
CountryUS
Kind codeA1
Filing dateSep 12, 2023
Priority dateDec 5, 2022
Publication dateMay 22, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A D-amino acid oxidase mutant with significantly improved catalytic performance, a gene encoding the gene, a vector containing the gene, a genetically engineered bacterium, and the application of the said mutant in the microbial catalytic preparation of L-ammonium glufosinate. The D-amino acid oxidase mutant was obtained from the amino acid shown in SEQ ID NO.1 by single-point mutation or multi-point combined mutation. The beneficial effects are mainly reflected in the following: the D-amino acid oxidase mutant with improved enzyme activity and thermal stability can be used in the microbial catalysed preparation of L-ammonium glufosinate, which is conducive to industrial production and has a better application prospect.

First claim

Opening claim text (preview).

What is claimed is: 1 . A D-amino acid oxidase mutant, wherein the D-amino acid oxidase mutant is obtained by carrying out single-point mutation or multi-point combined mutation at positions 54, 58, 213, 239, 73, 77, 79, 147, 185, 43, 45, 206, 207, 215, 122, 132, 195, and 234 of an amino acid sequence as shown in SEQ ID NO. 1. 2 . The D-amino acid oxidase mutant according to claim 1 , wherein the D-amino acid oxidase mutant comprises one of the following mutations: (1) mutation of an amino acid residue N at the position 54 to V, D or T, mutation of an amino acid residue F at the position 58 to H, R, K or Q, and mutation of an amino acid residue M at the position 213 to S, N or R; (2) mutation of the amino acid residue N at the position 54 to V, D or T, mutation of the amino acid residue F at the position 58 to H, R, K or Q, mutation of the amino acid residue M at the position 213 to S, N or R, and mutation of an amino acid residue L at the position 239 to E, D, G or Q; (3) mutation of the amino acid residue N at the position 54 to V, D or T, mutation of the amino acid residue F at the position 58 to H, R, K or Q, mutation of the amino acid residue M at the position 213 to S, N or R, mutation of the amino acid residue L at the position 239 to E, D, G or Q, mutation of an amino acid residue A at the position 73 to L, mutation of an amino acid residue Q at the position 77 to W, mutation of an amino acid residue V at the position 79 to M, mutation of an amino acid residue Q at the position 147 to M, and mutation of an amino acid residue S at the position 185 to M; (4) mutation of the amino acid residue N at the position 54 to V, D or T, mutation of the amino acid residue F at the position 58 to H, R, K or Q, mutation of the amino acid residue M at the position 213 to S, N or R, mutation of the amino acid residue L at the position 239 to E, D, G or Q, mutation of an amino acid residue A at the position 43 to S, mutation of an amino acid residue T at the position 45 to M, mutation of an amino acid residue S at the position 206 to A, mutation of an amino acid residue D at the position 207 to P, and mutation of an amino acid residue S at the position 215 to F; and (5) mutation of the amino acid residue N at the position 54 to V, D or T, mutation of the amino acid residue F at the position 58 to H, R, K or Q, mutation of the amino acid residue M at the position 213 to S, N or R, mutation of the amino acid residue L at position 239 to E, D, G or Q, mutation of an amino acid residue E at the position 122 to P, mutation of an amino acid residue Y at the position 132 to F, mutation of an amino acid residue E at the position 195 to Y, and mutation of an amino acid residue C at the position 234 to L. 3 . The D-amino acid oxidase mutant according to claim 2 , wherein an amino acid sequence of the mutant is shown in one of SEQ ID NO. 2 to SEQ ID NO. 7. 4 . A gene encoding the D-amino acid oxidase mutant according to claim 1 . 5 . A recombinant vector containing the gene encoding the D-amino acid oxidase mutant according to claim 1 . 6 . Genetically engineered bacteria containing the gene encoding the D-amino acid oxidase mutant according to claim 1 . 7 . An application of the D-amino acid oxidase mutant according to claim 1 in preparation of L-phosphinothricin through microbial catalysis.

Assignees

Inventors

Classifications

  • C12N9/0024Primary

    D-Amino acid oxidase (1.4.3.3) · CPC title

  • D-Amino-acid oxidase (1.4.3.3) · CPC title

  • C12P13/04Primary

    Alpha- or beta- amino acids {(other amino acids C12P13/005)} · CPC title

  • Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title

  • Escherichia coli · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025163390A1 cover?
A D-amino acid oxidase mutant with significantly improved catalytic performance, a gene encoding the gene, a vector containing the gene, a genetically engineered bacterium, and the application of the said mutant in the microbial catalytic preparation of L-ammonium glufosinate. The D-amino acid oxidase mutant was obtained from the amino acid shown in SEQ ID NO.1 by single-point mutation or multi…
Who is the assignee on this patent?
Univ Zhejiang Technology
What technology area does this patent fall under?
Primary CPC classification C12N9/0024. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu May 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).